Intravenous immune globulin for acute myocarditis in children and adults

  • Protocol
  • Intervention


  • J Robinson,

    Associate Clinical Professor, Corresponding author
    1. University of Alberta, Pediatrics, Edmonton, Alberta, CANADA
    • J Robinson, Associate Clinical Professor, Pediatrics, University of Alberta, 2C3.77 Walter C Mackenzie, Health Sciences Center, Edmonton, Alberta, T6G 2R7, CANADA.

    Search for more papers by this author
  • E Crumley,

  • L Hartling,

  • TP Klassen,

  • N Wiebe


This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to compare the outcome of patients with acute myocarditis treated with IVGG to the outcome of patients who did not receive IVGG, particularly with respect to transplant-free survival. The review will attempt to determine if there is an identifiable group of acute myocarditis patients (based on age, duration of symptoms, acuity of onset of symptoms, cardiac function at presentation, virologic results, or the presence or absence of histologic evidence of acute myocarditis on cardiac biopsy in patients where a biopsy was performed) who would benefit from IVGG.